Organizing Committee Members
OCM Member
Chaired professor and Director of Theragnostic compound R&D center, Radiology
Gachon University , South Korea
Biography :

Tatsuo Ido PhD. Chaired Professor and Director of Theragnostic compound R&D center, Neuroscience Research Institute, Gachon University ( Republic of Korea) and Emeritus Professor of Tohoku University (Japan). He had completed his PhD. of Pharmaceutical Sciences at Graduate school of Tokyo University (Tokyo, Japan) in 1970. He has investigated in PET radiopharmaceuticals in near 50 years at National Institute of Radiological Sciences ( Chiba, Japan), Brookhaven National Institute (Long Island, USA) and Tohoku University (Sendai, Japan). In 1976 at BNL, he had succeeded first synthesis of 18FDG and applied to human brain functional study. After retired of professor of Tohoku University, He had continuous research work as professor of High energy Biomedical Research Center of Fukui University ( Fukui, Japan). From 2007 to 2012, he had leaded to stable supply of radioisotopes in Japan at Japan Radioisotope Association as executive director. From 2013 until present, he is working continuously in development new PET radiopharmaceuticals in Neuroscience research field.

OCM Member
Neurosurgeon,MD, MSc, FRCS(C) , Neurosurgery
University of Toronto , Canada
Research Interest :

Neurosurgery , surgical spinal pathologies and closed head injuries.

OCM Member
Boston University , Massachusetts General Hospital
Harvard Medical School , USA
Biography :

Dr. Vaina presently serves at Boston University as a Professor in the Department of Biomedical Engineering and a Research Professor of Neurology in the School of Medicine. Dr. Vaina is also associated with the Neurology Department at Massachusetts General Hospital and the Harvard Medical School-Department of Neurology. She is on the faculty of the Athinoula A. Martino’s Center for Biomedical Imaging at Harvard University and a Research Affiliate in the Center for Biological and Computational Learning at Massachusetts Institute of Technology, Department of Brain and Cognitive Science. She is Director of the Brain and Vision Research Laboratory at Boston University and co-director of the Neurology of Vision Laboratory at Massachusetts General Hospital. Dr. Vaina’s research is in core problems in cognitive neuroscience and neurology. She is using various methods including experimentation/psychophysics, computational modeling, neuropsychological & behavioral neurology approaches with brain-damaged patients, functional magnetic resonance imaging (fMRI), and magneto encephalography (MEG). Dr. Vaina has published 144 peer-reviewed research articles and has authored/edited five books on cognitive and visual science. She served as a charter member of the National Institute of Health (NIH) Perception and Cognition Study Section, and on the National Science Foundation, Brain Initiative Review Panel. She is the chief editor of the American Journal of Case Reports and the Section Editor on Neuroscience & Neurology of the Medical Science Monitor. In 2000 Dr. Vaina was nominated the Millennium Professor at the University of Bologna, and between 2003 and 2006 she held the prestigious Rientro dei Cervelli Award at the same University. She has been elected a fellow of the American Institute for Medical and Biological Engineering (2004) and she received a doctorate Honoris Causa in Medicine-Neurology, from the Vasile Goldis University, Romania. Dr. Vaina holds a Ph. D. in Mathematical Logic from Sorbonne, France, and a M.D./Ph.D. from the University of Toulouse, France. She completed postdoctoral training in cognitive neuroscience and artificial Intelligence at the UC Berkeley, Stanford University, Massachusetts Institute of Technology, and Harvard Medical School. Board of Advisory in Quantum Innovation Corporation

OCM Member
Assistant Professor, Parkinson's Disease & Movement Disorders
Weill Cornell Medical College , USA
Biography :

Dr. Alexander Shtilbans is an Assistant Professor of Neurology at the Parkinson's Disease & Movement Disorders Institute of Weil Cornell Medical College. He is a Movement Disorders specialist whose clinical and research interests are in the area of Neurodegenerative diseases in general and in Parkinson disease and ALS in particular. Having started out as a molecular biologist in Neuroscience, after obtaining his Ph.D., he had transitioned into clinical Neurology to work with patients and to better understand the clinical course of the diseases. Dr. Shtilbans received his medical degree from Mount Sinai School of Medicine where he also completed his residency in Neurology and served as a chief resident. Subsequently, he completed his clinical fellowship in Movement Disorders at Columbia University. Dr. Shtilbans has a longstanding interest in translational research and currently leads several NIH-funded clinical trials on Parkinson's Disease as a principal investigator and also is involved in studies on Amyotrophic Lateral Sclerosis. As a physician scientist, Dr. Shtilbans is interested in developing new therapies for neurodegenerative diseases. His goal is to better understand molecular mechanisms of the neurodegenerative processes by being actively involved in both clinical and basic science research. He has published in peer-reviewed journals and received awards from the American Academy of Neurology.

OCM Member
Senior Investigator, Laboratory of Neurochemistry
National Institute of Neurological Disorders and stroke , USA
Biography :

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

OCM Member
Professor Emeritus, Medical Biology
University of Tromsø , Norway
Biography :

Dr. M. Raafat El-Gewely currently is Professor Emeritus, Institute of Medical Biology, U. of Tromsø, Norway. Professor of Biotechnology, Inst. of Medical Biology, U. of Tromsø, Norway, July 1988-July 2012 (Appointed by king Olav of Norway); Director of Biotechnology Center, University of Tromsø 1989-1999, Assoc. Research Scientist, Department of Biological Chemistry, U.of Michigan Medical School. Ann Arbor, Michigan1983-1988; Visiting Scholar, Dept. of Cellular and Molec. Biology, U. of Michigan, 1977-1983. Visiting or Adjunct professor at U. of California Medical School, San Diego (UCSD). Aug. 2008-Aug. 2009; Institute for Systems Biology (ISB), 1441 North 34th Street, Seattle, WA 98103-8904 Sept. 2003- Sept. 2004; Adjunct Professor, Dept. of Biotechnology, U.of Aalborg, 9000-Aalborg, Denmark 1997-2002; Dept. of Microbiology and Immunology, Medical School, U. of Michigan, Ann Arbor, MI 48109- 0620, Aug 1998 to Aug 1999; Dept. of Biological Chemistry, Medical School, U. of Michigan, Ann Arbor, MI 48109-0606/ Aug.1992 to Aug. 1993. Chief Editor, “Biotechnology Annual Review" (1995- 2009). Elsevier, Amsterdam. Netherlands. http://www.sciencedirect.com/science/bookseries/13872656. Reviews Editor New Biotechnology (2008-2015): Elsevier, Amsterdam, Netherlands. http://www.elsevier.com/wps/find/journaleditorialboard.cws_home/713354, B.SC. Alexandria, PhD in genetics, U. of Alberta, Edmonton Alberta, Canada in 1971, Post doctorate, McGill University, Montreal, Canada 1971-1973. Assistant professor Genetics (1973-1977. Prof. El-Gewely has extensive research experience in in molec. biology & recombinant DNA and genetic & protein engineering technologies with numerous publications. Developing therapeutics using a novel alternative approach to gene therapy and genetic control of protein folding (patents). Focused in the utilizations of recombinant DNA, genetic & protein engineering and genomics in the translational applications in medicine.

OCM Member
BC Neurologist & Clinical Neurophysiologist
Robert Wood Johnson Medical School , USA
Biography :

Dr. Elena Frid is a Board Certified Neurologist and Clinical Neurophysiologist, widely regarded as a investigating diagnostician, adviser and treatment strategist specializing in Infections Induced Autoimmune Disorders. With clinical interests in the Autoimmune Neurology, she often sees patients (children and adults) with complex cases of Lyme disease and co-infections resulting in multiple neurological complaints. Her many areas of expertise are: General Neurology, Headaches & Migraines, as well as sub-clinical focus in Autoimmune Neurology, Neuropsychiatric and Neurodegenerative Disorders. Using cutting edge diagnostic tools and clinical expertise she is able to help differentiate between idiopathic vs organic causes of various neurological disorders. Her knowledge has been sought by patients from all over the United States, as well as Canada and Europe. Dr. Frid attended a coveted BA/MD program at Robert Wood Johnson Medical School (RWJMS) and went on to North Shore-LIJ Health Caare Systems (currently Northwell) where she completed residency in Neurology and fellowship in Clinical Neurophysiology (EMG / EEG). Dr. Frid is a member of the American Academy of Neurology (AAN). She is a voting member of the International Lyme and Associated Diseases Society (ILADS), Medical Adviser to Project Lyme organization, Vice President of Robert Wood Johnson Medical School Alumni Association, and a member of the Independent Physicians of New York (IDNY). Upon request from families, Dr. Frid frequently collaborates on complex pediatric cases of Neuro Lyme disease with Dr. Charles Ray Jones, a world leading pediatric Lyme disease specialist with over 40 year career experience in dealing with children with Lyme disease and other Tick Borne Illnesses.

Mail us at

For any query.Please Contact
neurology@alliedconferences.org
For any query.Please Contact
neurology@alliedconference.com
Media Partner/Sponser/Exhibitor.
neurology@alliedmeetings.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact neurology@alliedconferences.org, to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrants account.

This cancellation policy was last updated on April 04, 2015.

Cancellation, Postponement and Transfer of Registration 

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to finance@alliedacademies.com . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies  if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.
The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-
  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

Copyright © 2017-2018 Allied Academies, All Rights Reserved.